Title:
骨形成不全症の処置における抗スクレロスチン抗体の使用
Document Type and Number:
Japanese Patent JP7050335
Kind Code:
B2
Abstract:
Disclosed are methods for treating a patient suffering from osteogenesis imperfecta comprising administering to the patient a therapeutically effective amount of an anti-sclerostin antibody. Methods for increasing bone formation and reducing bone resorption in an osteogenesis imperfecta patient by administering to the patient a therapeutically effective amount of an anti-sclerostin antibody are also disclosed. Further disclosed are compositions for increasing bone formation and reducing bone resorption in an osteogenesis imperfecta patient. The compositions comprise a therapeutically effective amount of an anti-sclerostin antibody. The invention also provides an anti-sclerostin antibody for use in the treatment of osteogenesis imperfecta.
Inventors:
Junker, Uwe
Kunisel, Micaela
Hull, Antony Kent
Judi, Lena Joy
Riggs, Matthew Manning
Kunisel, Micaela
Hull, Antony Kent
Judi, Lena Joy
Riggs, Matthew Manning
Application Number:
JP2019533586A
Publication Date:
April 08, 2022
Filing Date:
December 21, 2017
Export Citation:
Assignee:
Meleo by Offerma 3 Limited
International Classes:
A61K39/395; A61P19/08
Domestic Patent References:
| JP2016121170A |
Other References:
Journal of Bone and Mineral Research,2016年05月,Vol. 31, No. 5,p.1030-1040
Attorney, Agent or Firm:
Hiroshi Kobayashi
Norio Omori
Noriki Mihashi
Norio Omori
Noriki Mihashi
Previous Patent: Optical RF spectrum analyzer
Next Patent: Deuterated compounds and their pharmaceutical uses
Next Patent: Deuterated compounds and their pharmaceutical uses